- $24.24bn
- $23.04bn
- $2.80bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 508 | 924 | 1,919 | 2,225 | 2,799 |
Cost of Revenue | |||||
Gross Profit | 386 | 684 | 1,422 | 1,677 | 2,150 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 585 | 1,190 | 2,414 | 3,149 | 4,058 |
Operating Profit | -76.4 | -266 | -495 | -924 | -1,259 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -71.1 | -264 | -504 | -931 | -1,158 |
Provision for Income Taxes | |||||
Net Income After Taxes | -71.1 | -258 | -503 | -934 | -1,159 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -71 | -253 | -492 | -924 | -1,152 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -71 | -253 | -492 | -924 | -1,152 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.129 | -0.46 | -0.839 | -1.55 | -1.85 |
Dividends per Share |